A Prescription for "Deprescribing" in Psychiatry.

The term "deprescribing," initially coined in geriatric medicine, describes a process of pharmacologic regimen optimization through reduction or cessation of medications for which benefits no longer outweigh risks. Burgeoning rates of polypharmacy, growing appreciation of long-term adverse effects,...

Descripción completa

Detalles Bibliográficos
Publicado en:Psychiatric Services Vol. 67; no. 8; pp. 904 - 908
Autores principales: Gupta, Swapnil, Cahill, John Daniel
Formato: review Journal Article
Publicado: American Psychiatric Publishing, Inc. Aug2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=117045631&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 117045631
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10752730
        0Y1
      jtl: Psychiatric Services
      issn: 10752730
      maglogo: N
    pubinfo:
      dt: Aug2016
      vid: 67
      iid: 8
      pid: 37323
      pub: American Psychiatric Publishing, Inc.
      place: Arlington, Virginia
    artinfo:
      ui:
        117045631
        117045631
        NLM26975524
        117045631
        10.1176/appi.ps.201500359
        NLM26975524
        117045631
      ppf: 904
      ppct: 4
      formats:
      tig:
        atl: A Prescription for "Deprescribing" in Psychiatry.
      aug:
        au:
          Gupta, Swapnil
          Cahill, John Daniel
        affil: Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
      sug:
        subj:
          Psychiatry Methods
          Psychiatry Standards
      ab: The term "deprescribing," initially coined in geriatric medicine, describes a process of pharmacologic regimen optimization through reduction or cessation of medications for which benefits no longer outweigh risks. Burgeoning rates of polypharmacy, growing appreciation of long-term adverse effects, and a focus on patient-centered practice present specific indications for deprescribing in psychiatry. A strong therapeutic alliance, appropriate timing, and consideration of the meaning of medication for the patient must accompany the following established elements: review of all medications, identification of medications that could be ceased or reduced, collaborative planning of the deprescribing regimen, and provision of review and support to the patient and caregivers. The authors discuss how deprescribing might be adapted for and implemented in psychiatry, identify potential barriers, and make recommendations for future directions.
      pubtype: Academic Journal
      doctype:
        review
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N